Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients. | Front Immunol | 2023 | 37215103 | PubTator, text mining | PubMed |
| Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy. | Front Immunol | 2023 | 37205115 | PubTator, text mining | PubMed |
| Proteomic profiling of extracellular vesicles in synovial fluid and plasma from Oligoarticular Juvenile Idiopathic Arthritis patients reveals novel immunopathogenic biomarkers. | Front Immunol | 2023 | 37205098 | PubTator, text mining | PubMed |
| Intestinal endothelial cells increase HIV infection and latency in resting and activated CD4 + T cells, particularly affecting CCR6 + CD4 + T cells. | Retrovirology | 2023 | 37202790 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Chronic Lymphocytic Leukemia: Tumor Microenvironment Messengers as a Basis for New Targeted Therapies? | Cancers (Basel) | 2023 | 37190234 | PubTator, text mining | PubMed |
| Large B-Cell Lymphomas in the 5th Edition of the WHO-Classification of Haematolymphoid Neoplasms-Updated Classification and New Concepts. | Cancers (Basel) | 2023 | 37190213 | PubTator, text mining | PubMed |
| CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukaemia. | Biomol Biomed | 2023 | 37183704 | PubTator, text mining | PubMed |
| Genetic immune escape landscape in primary and metastatic cancer. | Nat Genet | 2023 | 37165135 | PubTator, text mining | PubMed |
| cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity. | Immunity | 2023 | 37160118 | PubTator, text mining | PubMed |
| Advances in the Mechanism of Luteolin against Hepatocellular Carcinoma Based on Bioinformatics and Network Pharmacology. | J Cancer | 2023 | 37151401 | PubTator, text mining | PubMed |
| LCL161 enhances expansion and survival of engineered anti-tumor T cells but is restricted by death signaling. | Front Immunol | 2023 | 37138866 | PubTator, text mining | PubMed |
| BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma. | J Immunother Cancer | 2023 | 37137553 | PubTator, text mining | PubMed |
| Anaplastic large cell lymphomas with the 6p25.3 rearrangement are a heterogeneous group of tumours with a diverse molecular background. | Hum Pathol | 2023 | 37127078 | PubTator, text mining | PubMed |
| Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma. | World J Clin Oncol | 2023 | 37124135 | PubTator, text mining | PubMed |
| Applications of single-cell RNA sequencing in drug discovery and development. | Nat Rev Drug Discov | 2023 | 37117846 | PubTator, text mining | PubMed |
| Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia. | Viruses | 2023 | 37112825 | PubTator, text mining | PubMed |
| The Philadelphia Chromosome, from Negative to Positive: A Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell Transplantation. | Medicina (Kaunas) | 2023 | 37109629 | PubTator, text mining | PubMed |
| Evaluation of T cell responses with the QuantiFERON SARS-CoV-2 assay in individuals with 3 doses of BNT162b2 vaccine, SARS-CoV-2 infection, or hybrid immunity. | Diagn Microbiol Infect Dis | 2023 | 37094435 | PubTator, text mining | PubMed |
| MYD88L265P and MYD88other variants show different molecular characteristics and prognostic significance in diffuse large B-cell lymphoma. | J Cancer Res Clin Oncol | 2023 | 37093346 | PubTator, text mining | PubMed |
| Genetic subdivisions of follicular lymphoma defined by distinct coding and noncoding mutation patterns. | Blood | 2023 | 37084389 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=17